Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

257 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Clinical Relevance of the IBD-Associated Variation within the Risk Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 2 in Patients of the Swiss IBD Cohort.
Spalinger MR, Voegelin M, Biedermann L, Zeitz J, Rossel JB, Sulz MC, Frei P, Scharl S, Vavricka SR, Fried M, Rogler G, Scharl M; Swiss IBD Cohort Study Group. Spalinger MR, et al. Among authors: scharl s, scharl m. Digestion. 2016;93(3):182-92. doi: 10.1159/000444479. Epub 2016 Feb 27. Digestion. 2016. PMID: 26928573 Free article.
[Biologicals in gastroenterology: TNF-blockers].
Scharl M, Rogler G. Scharl M, et al. Dtsch Med Wochenschr. 2010 Nov;135(45):2243-52. doi: 10.1055/s-0030-1267508. Epub 2010 Nov 2. Dtsch Med Wochenschr. 2010. PMID: 21046532 Review. German.
Efficacy and safety of certolizumab pegol in an unselected crohn's disease population: 26-week data of the FACTS II survey.
Vavricka SR, Schoepfer AM, Bansky G, Binek J, Felley C, Geyer M, Manz M, Rogler G, de Saussure P, Sauter B, Scharl M, Seibold F, Straumann A, Michetti P; Swiss IBDnet. Vavricka SR, et al. Among authors: scharl m. Inflamm Bowel Dis. 2011 Jul;17(7):1530-9. doi: 10.1002/ibd.21521. Epub 2010 Dec 22. Inflamm Bowel Dis. 2011. PMID: 21674709 Clinical Trial.
257 results